Others are carcinoembryonic antigen (CEA), a tumour biomarker linked with liver, colorectal, ovarian, breast and lung cancer, and prostate-specific antigen (PSA), the biomarker for detecting prostate cancer [1,2,3]. This evidence concerns the gene CEACAM5 and prostate cancer.